All Updates

All Updates

icon
Filter
Earnings/results
C3 AI reports Q4 FY2023 results; beats EPS estimates
Machine Learning Infrastructure
May 31, 2023
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Yesterday
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Machine Learning Infrastructure

Machine Learning Infrastructure

May 31, 2023

C3 AI reports Q4 FY2023 results; beats EPS estimates

Earnings/results

  • C3 AI reported a non-GAAP loss per share of USD 0.13 in Q4 FY2023, better than analysts' estimated loss per share of 0.17 and 0.21 recorded over the same period last year. Net loss for the quarter worsened by 11.2% YoY to USD 65.0 million from USD 58.4 million in Q4 FY2022, primarily due to an increase in operating expenses (up 8.3% YoY).

  • It generated a gross profit of USD 47.5 million (down 13.6% YoY) in Q4 FY2023, translating to a gross profit margin of 65.6% (down 10.4 percentage points YoY). This was attributable to higher Subscription cost of sales, which nearly doubled to USD 23.9 million during the quarter.

  • Total revenue improved marginally to USD 72.4 million (up 0.1% YoY), on the back of higher Subscription revenue of USD 56.9 million (up 1.0% YoY), partly offset by lower Professional fees, which declined 2.9% YoY to USD 15.5 million.

  • For the full year of FY2023, C3 AI reported total revenue of USD 266.8 million (up 5.6% YoY) and a net loss of USD 268.8 million, compared to USD 192.1 million in the prior year.

  • In terms of guidance, the company projects to generate total revenue between USD 70.0 million–72.5 million (implying a growth rate of 7.2%–11.0% YoY) and non-GAAP loss from operations between USD 25.0 million–30 million (vs loss of USD 14.5 million in Q1 FY2023) in Q1 FY2024. For the full year of FY2024, it estimates to generate total revenue between USD 295.0 million–320.0 million (implying a growth rate of 10.6%–19.9% YoY) and non-GAAP loss from operations between USD 50.0 million–75.0 million (vs loss of USD 68.1 in FY2023).

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.